NVNO enVVeno Medical Corporation

Fundamentals / CIK 0001661053 / USD

enVVeno Medical Corporation reported $19.49M in total assets and a net loss of $15.55M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NVNO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$3.02M$1.51M$0-$23.10MFY 2017 Revenue: $422KFY 2017 Net Income: -$7.79M2017FY 2018 Revenue: $187KFY 2018 Net Income: -$13.04M2018FY 2019 Revenue: $31KFY 2019 Net Income: -$7.63M2019FY 2020 Net Income: -$9.14M2020FY 2021 Net Income: -$16.53M2021FY 2022 Net Income: -$24.67M2022FY 2023 Net Income: -$23.52M2023FY 2024 Net Income: -$21.82M2024FY 2025 Net Income: -$19.47M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- $31K $187K $422K
Cost of Revenue -- -- -- -- -- -- -- -- $420K
Gross Profit -- -- -- -- -- -- -- $187K $2.5K
Research & Development $9.98M $12.25M $13.58M $9.91M $5.73M $4.25M $2.21M $1.24M $650K
Selling, General & Admin $10.92M $11.58M $11.65M $15.02M $11.16M $4.88M $4.91M $6.48M $5.46M
Operating Income -$20.90M -$23.83M -$25.24M -$24.93M -$16.89M -$9.14M -$7.68M -$7.85M -$6.10M
EBITDA -$20.76M -$23.64M -$25.02M -$24.72M -$16.74M -$9.04M -$7.55M -$7.72M -$5.96M
Interest Income $692K $389K $180K $161K -- -- -- -- --
Interest Expense -- -- -- -- -- -- -- $305K $173K
Income Before Tax -$19.47M -$21.82M -- -- -- -- -- -- --
Net Income -$19.47M -$21.82M -$23.52M -$24.67M -$16.53M -$9.14M -$7.63M -$13.04M -$7.79M
Basic EPS -$33.06 -$44.53 -$66.78 -$76.92 -$66.43 -$263.64 -$423.08 -$1,529.72 -$1,180.07
Diluted EPS -$33.06 -$44.53 -$66.78 -$76.92 -$66.43 -$263.64 -$423.08 -$1,529.72 -$1,180.07
Basic Shares Outstanding 589.0K 490.0K 351.8K 321.2K 248.2K 36.9K 18.0K 10.7K 7.0K
Diluted Shares Outstanding 589.0K 490.0K 351.8K 321.2K 248.2K 36.9K 18.0K 10.7K 7.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.88M $2.08M $2.11M $1.95M $2.58M $2.89M $2.56M $3.51M
Selling, General & Admin $1.66M $1.72M $1.95M $2.06M $2.30M $4.16M $2.40M $3.19M
Operating Income -$4.53M -$3.80M -$4.06M -$4.01M -$4.88M -$7.05M -$4.95M -$6.70M
EBITDA -- -- -$4.03M -$3.98M -$4.85M -$7.01M -$4.91M -$6.66M
Interest Income $16K $9.0K $22K $103K $175K $195K $219K $163K
Net Income -$4.37M -$3.60M -$3.85M -$3.74M -$4.54M -$6.69M -$4.50M -$6.23M
Basic EPS -$6.29 -$5.37 -$5.89 -- -$7.89 -$11.52 -$7.75 --
Diluted EPS -$6.29 -$5.37 -$5.89 -- -$7.89 -$11.52 -$7.75 --
Basic Shares Outstanding 694.0K 671.0K 654.0K -- 575.0K 581.0K 581.0K --
Diluted Shares Outstanding 694.0K 671.0K 654.0K -- 575.0K 581.0K 581.0K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.06M $1.75M $3.62M $4.55M $54.73M $9.33M $1.31M $2.74M $78K
Short-Term Investments $25.15M $41.40M $42.79M $34.49M -- -- -- -- --
Cash & Short-Term Investments $28.21M $43.15M $46.41M $39.04M $54.73M $9.33M $1.31M $2.74M $78K
Accounts Receivable, Net -- -- -- -- -- -- -- $32K $35K
Total Current Assets $28.83M $43.73M $46.92M $39.44M $55.04M $9.57M $1.42M $2.84M $170K
Property, Plant & Equipment, Net $51K $182K $334K $521K $618K $399K $344K $26K $24K
Intangible Assets -- -- -- -- -- -- -- $666K $1.11M
Total Non-Current Assets $736K $1.22M $1.71M $2.23M $2.66M $969K $2.01M $722K $2.04M
Total Assets $29.56M $44.95M $48.63M $41.66M $57.70M $10.54M $3.43M $3.56M $2.21M
Accounts Payable $358K $1.01M -- $1.22M $560K $1.39M $1.22M $1.08M $1.45M
Deferred Revenue (Current) -- -- -- -- -- $33K $33K -- $103K
Total Current Liabilities $2.12M $2.10M $1.37M $1.53M $1.58M $3.19M $1.88M $1.52M --
Total Non-Current Liabilities $310K $700K $1.06M $1.40M $1.72M $254K $568K $0 --
Total Liabilities $2.43M $2.79M $2.44M $2.93M $3.29M $3.44M $2.44M $1.52M $8.17M
Total Debt (incl. Leases) $700K $1.06M $1.40M $1.72M $2.01M $568K $857K -- --
Common Stock -- -- -- -- $95 $25 $7 $117 $61
Retained Earnings -$171.3M -$151.9M -$130.0M -$106.5M -$81.85M -$65.32M -$56.19M -$48.56M -$35.52M
Total Stockholders' Equity $27.13M $42.16M $46.20M $38.73M $54.40M $7.10M $990K $2.04M -$11.13M
Total Equity $27.13M $42.16M $46.20M $38.73M $54.40M $7.10M $990K $2.04M -$11.13M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.58M $2.84M $2.60M $3.06M $1.54M $2.04M $2.94M $1.75M
Short-Term Investments $15.89M $18.64M $22.33M $25.15M $29.41M $33.10M $36.00M $41.40M
Cash & Short-Term Investments $18.47M $21.49M $24.93M $28.21M $30.95M $35.14M $38.94M $43.15M
Total Current Assets $19.02M $22.08M $25.49M $28.83M $31.50M $35.60M $39.48M $43.73M
Property, Plant & Equipment, Net $62K $78K $16K $51K $82K $113K $142K $182K
Total Non-Current Assets $469K $578K $608K $736K $853K $973K $1.10M $1.22M
Total Assets $19.49M $22.66M $26.10M $29.56M $32.35M $36.58M $40.58M $44.95M
Accounts Payable $1.08M $540K $813K $358K -- -- -- $1.01M
Total Current Liabilities $2.59M $1.89M $2.14M $2.12M $2.40M $3.02M $1.66M $2.10M
Total Non-Current Liabilities $0 $103K $207K $310K $505K $505K $609K $700K
Total Liabilities $2.59M $1.99M $2.35M $2.43M $2.90M $3.52M $2.27M $2.79M
Total Debt (incl. Leases) $408K $505K $603K $700K $791K $882K $979K $1.06M
Retained Earnings -$183.1M -$178.8M -$175.2M -$171.3M -$167.6M -$163.1M -$156.4M -$151.9M
Total Stockholders' Equity $16.90M $20.67M $23.75M $27.13M $29.45M $33.06M $38.31M $42.16M
Total Equity $16.90M $20.67M $23.75M $27.13M $29.45M $33.06M $38.31M $42.16M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$19.47M -$21.82M -$23.52M -$24.67M -$16.53M -$9.14M -$7.63M -$13.04M -$7.79M
Depreciation & Amortization $136K $189K $220K $212K $149K $98K $124K $133K $139K
Stock-Based Compensation $3.42M $4.14M $5.20M $8.99M $6.00M $881K $942K $1.92M $878K
Change in Receivables -- -- -- -- -- -- $32K $3.2K -$12K
Change in Inventory -- -- -- -- -- -- -- -- $91K
Change in Payables -- -- -$221K $88K -$833K $169K $144K -$294K $545K
Operating Cash Flow -$15.57M -$16.84M -$18.86M -$15.62M -$11.85M -$7.68M -$5.90M -$6.36M -$4.20M
Capital Expenditure -$5.0K -$37K -$33K -$115K -$368K -$180K -$364K -$12K -$11K
Free Cash Flow -$15.57M -$16.88M -$18.89M -$15.73M -$12.22M -$7.86M -$6.26M -$6.37M -$4.21M
Purchases of Investments -$46.02M -$55.57M -$56.52M -$48.13M -- -- -- -- --
Sales & Maturities of Investments $61.88M $56.94M $48.69M $13.69M -- -- -- -- --
Investing Cash Flow $15.86M $1.33M -$7.87M -$34.55M -$368K -$180K -$364K -$12K $165K
Common Stock Issued $782K -- $25.80M -- $57.36M $12.23M -- -- $1.29M
Financing Cash Flow $1.02M $13.64M $25.79M -- $57.61M $15.07M $5.64M $9.03M $4.06M
Net Change in Cash $1.31M -$1.87M -$935K -$50.17M $45.39M $7.22M -$623K $2.66M $21K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.37M -$3.60M -$3.85M -$3.74M -$4.54M -$6.69M -$4.50M -$6.23M
Depreciation & Amortization -- -- $31K $31K $31K $34K $40K $40K
Stock-Based Compensation $410K $397K $467K $637K $688K $1.44M $651K $1.02M
Operating Cash Flow -$3.18M -$3.55M -$3.24M -$3.44M -$4.39M -$3.71M -$4.02M -$5.11M
Capital Expenditure -- -- -- -- -- -- -- -$4.0K
Free Cash Flow -- -- -- -- -- -- -- -$5.11M
Purchases of Investments -$15.84M -$18.57M -$22.24M -$19.32M -$9.89M -$7.93M -$8.87M -$22.15M
Sales & Maturities of Investments $18.58M $22.24M $25.01M $23.50M $13.55M $10.76M $14.07M $11.10M
Investing Cash Flow $2.73M $3.67M $2.77M $4.18M $3.65M $2.82M $5.20M -$11.06M
Financing Cash Flow -- -- -- -- -- -- -- $0
Net Change in Cash -$256K $244K -$468K $1.52M -$500K -$893K $1.18M -$16.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- 100.0% 0.6%
Operating Margin -- -- -- -- -- -- -24566.5% -4210.5% -1445.9%
Net Profit Margin -- -- -- -- -- -- -24406.7% -6991.5% -1845.8%
Return on Equity (ROE) -71.8% -51.8% -50.9% -63.7% -30.4% -128.7% -770.3% -640.5% --
Return on Assets (ROA) -65.9% -48.5% -48.4% -59.2% -28.6% -86.7% -222.0% -366.4% -351.8%
Current Ratio 13.58x 20.88x 34.23x 25.78x 34.84x 3.00x 0.76x 1.86x --
Quick Ratio 13.30x 20.60x 33.85x 25.52x 34.64x 2.93x 0.70x 1.82x --
Debt to Equity 0.03x 0.03x 0.03x 0.04x 0.04x 0.08x 0.87x -- --
Revenue Growth (YoY) -- -- -- -- -- -- -83.3% -55.8% --
Gross Profit Growth (YoY) -- -- -- -- -- -- -- +7508.2% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -92.0% -76.1% -79.2% -71.8% -74.6% -69.8% -55.7% -51.8%
Return on Assets (ROA) -79.8% -69.4% -72.1% -65.9% -67.9% -63.1% -52.6% -48.5%
Current Ratio 7.35x 11.70x 11.89x 13.58x 13.12x 11.81x 23.77x 20.88x
Quick Ratio 7.13x 11.39x 11.63x 13.30x 12.90x 11.66x 23.44x 20.60x
Debt to Equity 0.02x 0.02x 0.03x 0.03x 0.03x 0.03x 0.03x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001661053) · from June 30, 2017 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal